Skip to main content

International Journal of Clinical Oncology

Ausgabe 2/2024

Including Invited Review on Robots in diagnostic and interventional radiology: current status

Inhalt (18 Artikel)

Invited Review Article

Robotic systems in interventional oncology: a narrative review of the current status

Yusuke Matsui, Tetsushi Kamegawa, Koji Tomita, Mayu Uka, Noriyuki Umakoshi, Takahiro Kawabata, Kazuaki Munetomo, Toshihiro Iguchi, Takayuki Matsuno, Takao Hiraki

Open Access Original Article

Platform trial for off-label oncology drugs using comprehensive genomic profiling under the universal public healthcare system: the BELIEVE trial

Sae Ishimaru, Tatsunori Shimoi, Kuniko Sunami, Miho Nakajima, Yayoi Ando, Natsuko Okita, Kenichi Nakamura, Taro Shibata, Yasuhiro Fujiwara, Noboru Yamamoto

Original Article

Concordance of ALK fusion gene-rearrangement between immunohistochemistry and next-generation sequencing

Kazushige Wakuda, Meiko Morita, Motoki Sekikawa, Noboru Morikawa, Keita Miura, Kosei Doshita, Yuko Iida, Hiroaki Kodama, Nobuaki Mamesaya, Haruki Kobayashi, Ryo Ko, Akira Ono, Hirotsugu Kenmotsu, Tateaki Naito, Haruyasu Murakami, Koji Muramatsu, Takuya Kawata, Keita Mori, Tetsuo Shimizu, Yasuhiro Gon, Toshiaki Takahashi

Original Article

Risk factors of secondary cancer in laryngeal, oropharyngeal, or hypopharyngeal cancer after definitive therapy

Goshi Nishimura, Hideaki Takahashi, Daisuke Sano, Yasuhiro Arai, Takashi Hatano, Yosuke Kitani, Nobuhiko Oridate

Original Article

Prognostic significance of initial tumor shrinkage in patients with stage III non-small cell lung cancer treated with durvalumab following chemoradiotherapy

Yuto Terashima, Taiki Hakozaki, Yuji Uehara, Akihiko Miyanaga, Kazuo Kasahara, Masahiro Seike, Yukio Hosomi

Original Article

Clinical significance of antinuclear antibody as prognostic marker for first-line pembrolizumab in advanced non-small cell lung cancer

Atsuto Mouri, Kyoichi Kaira, Ou Yamaguchi, Kosuke Hashimoto, Yu Miura, Ayako Shiono, Tomonori Kawasaki, Kunihiko Kobayashi, Hisao Imai, Hiroshi Kagamu

Original Article

Phase II study of S-1 plus docetaxel as first-line treatment for older patients with advanced gastric cancer (OGSG 0902)

Tomono Kawase, Hiroshi Imamura, Ryohei Kawabata, Jin Matsuyama, Kazuhiro Nishikawa, Kazuhiro Yanagihara, Kazuyoshi Yamamoto, Noriyuki Hoki, Junji Kawada, Hisato Kawakami, Daisuke Sakai, Yukinori Kurokawa, Toshio Shimokawa, Taroh Satoh

Original Article

Pegfilgrastim for the management of neutropenia during neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal cancer patients

Takanori Yoshimoto, Tadayuki Oshima, Takashi Fukada, Nobuko Imamura, Takashi Nakanishi, Nobuhiko Ebisutani, Daisuke Morishita, Masatoshi Mieno, Keisuke Nakai, Hiroo Sei, Yoshitaka Kitayama, Hirotsugu Eda, Takuya Okugawa, Toshihiko Tomita, Hirokazu Fukui, Shinichiro Shinzaki

Original Article

Diagnosis of colorectal cancer based on folate receptor-positive circulating tumor cell analysis: a retrospective cohort study

Zhi-jian Wei, Bai-chuan Zhou, Guo-xing Wang, Wen-xiu Han, Yong-xiang Li, A-man Xu

Original Article

Survival outcomes of patients with stage III colorectal cancer aged ≥ 80 years who underwent curative resection: the HiSCO-04 prospective cohort study

Tetsuya Mochizuki, Manabu Shimomura, Masahiro Nakahara, Tomohiro Adachi, Satoshi Ikeda, Yasufumi Saito, Yosuke Shimizu, Masatoshi Kochi, Yasuyo Ishizaki, Masanori Yoshimitsu, Yuji Takakura, Wataru Shimizu, Daisuke Sumitani, Shinya Kodama, Masahiko Fujimori, Mamoru Oheda, Hironori Kobayashi, Shintaro Akabane, Takuya Yano, Hideki Ohdan

Original Article

Clinical features and distribution of the APC variant in duodenal and ampullary polyps in patients with familial adenomatous polyposis: a multicenter retrospective cohort study in Japan

Yasuyuki Miyakura, Tatsuro Yamaguchi, Alan Kawarai Lefor, Sawako Tamaki, Akinari Takao, Misato Takao, Yoshiko Mori, Kenichi Chikatani, Hideyuki Ishida, Mitsuhiro Kono, Yoji Takeuchi, Hideki Ishikawa, Toshiya Nagasaki, Kazuhito Sasaki, Takaaki Matsubara, Keiji Hirata, Fumitaka Taniguchi, Kohji Tanakaya, Naohiro Tomita, Yoichi Ajioka

Original Article

Prognostic impact and survival outcomes of colon perforation in patients with metastatic colorectal cancer: a multicenter retrospective cohort study

Eiichi Nakao, Hidetaka Kawamura, Michitaka Honda, Yoshinao Takano, Shunji Kinuta, Takahiro Kamiga, Shigeru Yamazaki, Atsushi Muto, Satoru Shiraso, Naoyuki Yamashita, Toshiyasu Iwao, Koji Kono, Shinichi Konno

Original Article

Liposomal irinotecan plus fluorouracil/leucovorin in older patients with advanced pancreatic cancer: a single-center retrospective study

Shuhei Nagashima, Satoshi Kobayashi, Shotaro Tsunoda, Yui Yamachika, Yuichiro Tozuka, Taito Fukushima, Manabu Morimoto, Makoto Ueno, Junji Furuse, Shin Maeda

Original Article

Predictors for early recurrence beyond up-to-7 or distant metastasis after hepatocellular carcinoma resection: proposal for borderline resectable HCC

Norifumi Harimoto, Mariko Tsukagoshi, Takaomi Seki, Kouki Hoshino, Kei Hagiwara, Norihiro Ishii, Takamichi Igarashi, Kenichiro Araki, Koichiro Haruki, Toru Ikegami, Ken Shirabe

Original Article

Comparative assessment of disease recurrence after transurethral resection of non-muscle-invasive bladder cancer with and without a photodynamic diagnosis using 5-aminolevulinic acid: a propensity score-matching analysis

Yuto Matsushita, Makito Miyake, Nobutaka Nishimura, Koshiro Nishimoto, Hideo Fukuhara, Keita Kobayashi, Masafumi Oyama, Keiji Inoue, Hideyasu Matsuyama, Kiyohide Fujimoto, Hideaki Miyake

Original Article

Survival outcome of chemotherapy-naïve castration-resistant prostate cancer treated with new-generation androgen receptor axis-targeted agents in real-world analysis

Tatsuya Shimomura, Keiichiro Mori, Keiji Yasue, Akihiro Matsukawa, Wataru Fukuokaya, Takafumi Yanagisawa, Kenichi Hata, Masaya Murakami, Yusuke Koike, Jun Miki, Hiroki Yamada, Takahiro Kimura

Open Access Original Article

Phase 2 study of ibrutinib plus venetoclax in Japanese patients with relapsed/refractory mantle cell lymphoma

Hideki Goto, Satoshi Ito, Masahiro Kizaki, Masaki Yamaguchi, Noriko Fukuhara, Koji Kato, Toko Saito, Yasuhito Terui, Sumiko Okubo, Tomomi Soshin, Jiewei Zeng, Hideyuki Honda, Mohamed Badawi, Jeremy A. Ross, Koji Izutsu

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.